XML 21 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Marketable Investments
3 Months Ended
Mar. 31, 2017
Marketable Investments  
Marketable Investments

3.     Marketable Investments

 

Available-for-Sale Investments

 

Marketable investments classified as available-for-sale consisted of the following (in millions):

 

As of March 31, 2017

 

Amortized
Cost

 

Gross
Unrealized
Gains

 

Fair
Value

 

U.S. government and agency securities

 

$

311.8

 

$

0.1

 

$

311.9

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

311.8

 

$

0.1

 

$

311.9

 

 

 

 

 

 

 

 

 

 

 

 

Reported under the following captions on the consolidated balance sheet:

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

$

168.1

 

Non-current marketable investments

 

 

 

 

 

143.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

311.9

 

 

 

 

 

 

 

 

 

 

 

We had no available-for-sale investments as of December 31, 2016.

 

The following table summarizes the contractual maturities of available-for-sale marketable investments (in millions):

 

 

 

March 31, 2017

 

 

 

Amortized
Cost

 

Fair
Value

 

Due in less than one year

 

$

168.1

 

$

168.1

 

Due in one to two years

 

80.8

 

80.8

 

Due in three to five years

 

62.9

 

63.0

 

 

 

 

 

 

 

Total

 

$

311.8

 

$

311.9

 

 

 

 

 

 

 

 

 

 

Held-to-Maturity Investments and Other

 

The balance of our marketable investments classified as held-to-maturity was $9.3 million and $30.1 million as of March 31, 2017 and December 31, 2016, respectively. The March 31, 2017 balance also includes an investment of $25.1 million of time deposits which will mature in September 2017. Marketable investments classified as held-to-maturity are comprised of government-sponsored enterprises and corporate notes and bonds. We do not intend to sell these securities, nor is it more likely than not that we will be required to sell them prior to the recovery of their amortized cost basis. Furthermore, we do not believe that these securities expose us to undue market risk or counterparty credit risk. As such, we do not consider these securities to be other than temporarily impaired.